Vertex Pharmaceuticals could soon capture $10 billion in sales of non-opioid painkillers, an analyst said Friday as Vertex stock jumped.

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.

Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. Large-scale ...

INDIANAPOLIS — The state of Indiana is suing two of the world's biggest drug companies over the price of EpiPens. Attorney General Todd Rokita claims that Mylan and Pfizer have conspired to increase ...

Those new prices go into effect in January 2026. For the second group of drugs, discussions between the federal government and manufacturers will take up most of 2025. "Once again, we have a ...

Copyright 2025 The Associated Press. All Rights Reserved. President Joe Biden speaks about prescription drug costs at the National Institutes of Health in Bethesda ...

Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers, the Biden ...

Under the finalized guidance for the second negotiation cycle, drug manufacturers have until February 28, 2025, to decide on their participation. CMS will evaluate factors such as the drug's ...

The move could mean savings for consumers. Weight loss drugs Ozempic and Wegovy have been added to the list of medications Medicare will be able to negotiate directly with drug manufacturers ...

Much of the negotiation process took place in 2024, including CMS’s provision of an initial offer to the manufacturer of each selected drug, each manufacturer’s proposal of a counteroffer ...